Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
about
Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammationThrombin and vascular inflammationBIOLOGICAL ACTIVITIES OF C1 INHIBITORChemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathwaysPlasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system.High molecular weight kininogen activates B2 receptor signaling pathway in human vascular endothelial cellsNovel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator.Modulation of C1-Inhibitor and Plasma Kallikrein Activities by Type IV Collagen.Polyphosphate as modulator of hemostasis, thrombosis, and inflammationPlasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in childrenThe kallikrein-kinin system as a regulator of cardiovascular and renal function.How it all starts: Initiation of the clotting cascade.Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cellsThe arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimersKinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein.Portal hypertensive response to kinin.Prekallikrein deficiency.Reincarnation of ancient links between coagulation and complement.The initiation and effects of plasma contact activation: an overview.The effects of nanomaterials on blood coagulation in hemostasis and thrombosis.Kallikrein Promotes Inflammation in Human Dental Pulp Cells Via Protease-Activated Receptor-1.Hereditary angioedema therapy: kallikrein inhibition and bradykinin receptor antagonism.Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2.Activation of the contact system at the surface of Fusobacterium necrophorum represents a possible virulence mechanism in Lemièrre's syndrome.2D-LC-MS/MS to measure cleaved high-molecular-weight kininogen in human plasma as a biomarker for C1-INH-HAE.A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.Impact of Bradykinin Generation During Thrombolysis in Ischemic Stroke
P2860
Q26865798-9DCE8DD1-E319-45CA-B1AE-B221F5FAF074Q28246124-D8DE32E1-AD60-46C8-970C-60F68908C58AQ28972362-A1F779F7-76FF-458B-B184-A8969254C7EFQ34003880-D09B418C-7407-4215-BC6F-64828E8EF937Q34251521-AC470BE1-6B04-4696-B9C5-5D237B9ED0CDQ34845482-72A7499D-B655-47FB-9348-28A81BA3C512Q35107342-5F8AF4A5-CC55-4C9D-A798-2D21E6112974Q35112051-7CF49109-3956-4EAE-960D-6A7F8D993007Q35810616-F4302586-C088-47BD-AC68-9618F89CD7AFQ35835056-21ABD0F8-F465-41D7-83A3-18C40354DD52Q36100611-B649B6E0-3488-4857-B0C5-F3FC1E5012EDQ36389061-0606348F-A757-4166-ADD6-F231B2033254Q36783613-D824246A-0637-4C4F-9CE0-FBCD50B19730Q36919773-402958DE-F6F4-4AEA-A864-20AB74089481Q36967299-C2B88BCD-746D-45C4-86DF-65E1D66538A8Q37375631-E966B601-6CA7-414F-957C-35022E6EC920Q37590180-C0C5810F-8AB0-4C39-B9F0-C6650E044DC8Q38102909-B03810A5-7659-4F34-9A7E-7796E9FEC158Q38543278-06CFAF17-47B2-4D7E-AF33-94FD47AFF594Q38795041-9B3CFDC2-17F2-491F-8936-3E10CAB398E9Q39081782-A93B651C-9C2D-44EF-A61F-462217464871Q40323817-C07BC74F-E93B-4A4E-93CB-CF25E2DC7621Q41130419-36FA886E-008C-4F60-89E8-BDE50EB11072Q41855551-5988E8B0-A4B1-41A8-96B9-078AA26A7224Q41964436-FBADC571-21D0-4F35-84E0-8B83B54C6C8BQ47180647-155DC339-8FC2-4C7A-B3CC-BDBCAD159313Q50575704-0F83F342-D29C-437E-AB34-054CC8F89D87Q52148357-1C409B4D-4FDA-45D6-84BC-0C935D5C5334Q58179635-C816B15E-81C6-4CFA-B791-28C82FC8A225
P2860
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
@ast
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
@en
type
label
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
@ast
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
@en
prefLabel
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
@ast
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
@en
P2860
P1476
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
@en
P2093
Alvin H Schmaier
P2860
P304
P356
10.1016/J.INTIMP.2007.08.022
P577
2007-09-05T00:00:00Z